News

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...
For patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a study ...
Chew said that the "relatively small" new trial shows that "intravitreous injection of foselutoclax was not associated with worrisome safety signals and the secondary outcomes suggest that ...
“We are delighted that a single injection of K8 delivered via our unique drug-delivery ... K8, delivered via a sustained-release intravitreous implant, is the Company’s lead product for retinal ...
PAS-nomacopan is a long-acting bispecific inhibitor of C5 and leukotriene B4 (LTB4) product candidate that Akari believes has the potential for longer dose intervals between intravitreous injections ...
Expected to treat up to five subjects with intravitreous injection of intraocular implant designed to last for three months. Marks second clinical trial underway for Inflammasome Therapeutics that ...
This retrospective study included 66 eyes (62 consecutive patients) with nAMD who were treated with intravitreous injections of brolucizumab. Of the study eyes, 18 were treatment-naïve and 48 eyes had ...
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and ...
After 4 years, 34% of patients randomized to intravitreous aflibercept injections developed proliferative diabetic retinopathy (PDR) or center-involved diabetic macular edema (CI-DME) with vision ...
Sham injections (without drug ... Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic ...
KOLOA, Hawaii — Having a standard method of communication in place for staff helps prevent wrong intravitreous injections, according to a speaker here. During a Retina 2023 presentation ...